CAMBRIDGE, Mass., Nov. 20,
2023 /PRNewswire/ -- Akebia Therapeutics,
Inc. (Nasdaq: AKBA), a biopharmaceutical company with the
purpose to better the lives of people impacted by kidney disease,
today announced that John Butler,
Chief Executive Officer, will participate in a fireside chat at the
Piper Sandler 35th Annual Healthcare Conference on
Tuesday, November 28th at
10:30 a.m. EST.
The Piper Sandler Healthcare Conference will take place
November 28 – November 30, 2023, in New York.
A webcast of the fireside chat can be accessed through the
"Investors" section of Akebia's website at
https://ir.akebia.com for approximately 90 days following the
About Akebia Therapeutics
Akebia Therapeutics, Inc. is
a fully integrated biopharmaceutical company with the purpose to
better the lives of people impacted by kidney disease. Akebia was
founded in 2007 and is headquartered in Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Akebia Therapeutics Contact
View original content to download
SOURCE Akebia Therapeutics